Personalized Therapy for Multiple Myeloma

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book Personalized Therapy for Multiple Myeloma by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319618722
Publisher: Springer International Publishing Publication: October 30, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319618722
Publisher: Springer International Publishing
Publication: October 30, 2017
Imprint: Springer
Language: English

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

More books from Springer International Publishing

Cover of the book Advances in Condition Monitoring of Machinery in Non-Stationary Operations by
Cover of the book Euro-Par 2017: Parallel Processing Workshops by
Cover of the book Partial Least Squares Path Modeling by
Cover of the book Planning and Scheduling for Maritime Container Yards by
Cover of the book The Energy Consumption in Refrigerated Warehouses by
Cover of the book Urbanisation, unlimited by
Cover of the book Cohort Change Ratios and their Applications by
Cover of the book Mathematical Models for Remote Sensing Image Processing by
Cover of the book No More Free Lunch by
Cover of the book Enterprise and Organizational Modeling and Simulation by
Cover of the book Defects at Oxide Surfaces by
Cover of the book Mathematical Methods in Engineering by
Cover of the book Security-Aware Device-to-Device Communications Underlaying Cellular Networks by
Cover of the book The Discreet Charm of Protein Binding Sites by
Cover of the book Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy